NDAORALGRANULEPriority Review
Approved
Sep 2017
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
Pharmacologic Class:
Nitroimidazole Antimicrobial
Loss of Exclusivity
LOE Date
Dec 11, 2041
192 months away
Patent Expiry
Dec 11, 2041
Exclusivity Expiry
Sep 15, 2027